Iléana Antony-Debré, Ulrich Steidl  Cancer Cell 

Slides:



Advertisements
Similar presentations
HnRNP L and HnRNP A1 Induce Extended U1 snRNA Interactions with an Exon to Repress Spliceosome Assembly Ni-Ting Chiou, Ganesh Shankarling, Kristen W. Lynch.
Advertisements

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription Chia-Hsin.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
Nuclear Receptors, RXR, and the Big Bang Ronald M. Evans, David J. Mangelsdorf Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
Germline Energetics, Aging, and Female Infertility Jonathan L. Tilly, David A. Sinclair Cell Metabolism Volume 17, Issue 6, Pages (June 2013) DOI:
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Age-associated changes in human hematopoietic stem cells
T-ALL: Home Is where the CXCL12 Is
Dysfunctional Niches as a Root of Hematopoietic Malignancy
Building better therapy for children with acute lymphoblastic leukemia
Acute leukemia: A pediatric perspective
by Mario Cazzola, Marianna Rossi, and Luca Malcovati
An Alternative Sugar Fuels AML
Clinical Implications of Clonal Hematopoiesis
Leukemogenic Activity of Cohesin Rings True
The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient.
Adrian G. Selim, Andrew S. Moore  The Journal of Molecular Diagnostics 
Elodie Pronier, Ross L. Levine  Cancer Cell 
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Quit Stalling or You’ll Be Silenced
Andrew G. Muntean, Jay L. Hess  Cancer Cell 
Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs
Telomeres and Cancer: From Crisis to Stability to Crisis to Stability
Epidemiology of Myelodysplastic Syndromes
MDS Is a Stem Cell Disorder After All
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Alyson A. Lokken, Nancy J. Zeleznik-Le  Cancer Cell 
Daichi Inoue, Omar Abdel-Wahab  Cancer Cell 
The AML Salad Bowl Cancer Cell
New Views into the Genetic Landscape of Metastatic Breast Cancer
Tumor-Educated Platelets as Liquid Biopsy in Cancer Patients
Dysfunctional Niches as a Root of Hematopoietic Malignancy
Combinatorial Haplo-Deficient Tumor Suppression in 7q-Deficient Myelodysplastic Syndrome and Acute Myeloid Leukemia  Britta Will, Ulrich Steidl  Cancer.
Bringing IDH into the Fold
Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Volume 28, Issue 5, Pages (November 2015)
A New Therapeutic Target for Leukemia Comes to the Surface
Activation of a Cryptic Splice Site of PTEN and Loss of Heterozygosity in Benign Skin Lesions in Cowden Disease  Stephen J. Meltzer, Manfred Wolter  Journal.
MicroRNAs: From Decay to Decoy
Silent Mutations Make Some Noise
AML Therapy: Wake Up the Guardian and Cut Loose the Executioners
Meddling with METTLs in Normal and Leukemia Stem Cells
Alternative splicing in heart surgery: Lost in translation?
On the Origin of Leukemic Species
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Maria Kleppe, Ross L. Levine  Cancer Cell 
Crossing the Exon Molecular Cell
Chronic Lymphocytic Leukemia: Keeping Cell Death at Bay
Splicing and Dicing MYC-Mediated Synthetic Lethality
John D. Crispino, Michelle M. Le Beau  Cancer Cell 
It’s ALL in the Family: IKZF1 and Hereditary Leukemia
TFIID and MYB Share a Therapeutic Handshake in AML
Simón Méndez-Ferrer, María García-Fernández, Carlos L.F. de Castillejo 
Nicholas McGranahan, Charles Swanton  Cancer Cell 
Invasive Mycoses: Diagnostic Challenges
Attacking Cancer at Its Root
Searching for leukemia stem cells—Not yet the end of the road?
Ibrutinib Treatment of CLL: The Cancer Fights Back
Volume 12, Issue 6, Pages (December 2007)
Long Noncoding RNAs in Cancer Pathways
The AML Salad Bowl Cancer Cell
Targeting Protein Stability with a Small Molecule
The Role of TET2 in Hematologic Neoplasms
RNA Processing: Redrawing the Map of Charted Territory
Presentation transcript:

Functionally Relevant RNA Helicase Mutations in Familial and Sporadic Myeloid Malignancies  Iléana Antony-Debré, Ulrich Steidl  Cancer Cell  Volume 27, Issue 5, Pages 609-611 (May 2015) DOI: 10.1016/j.ccell.2015.04.013 Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 DDX41 Mutations in Myeloid Neoplasms (A) DDX41 mutations in familial and acquired MDS/AML. Germline mutations are consistent with a preleukemic state, whereas acquired mutations, including in the second allele of DDX41 (found in half of the patients), are necessary for leukemia initiation. Analysis of the clonal architecture at the leukemic stage revealed that acquired DDX41 mutations can be ancestral or be present in a subclone. Abbreviations: AML, acute myeloid leukemia; MDS, myelodysplastic syndrome. (B) Association of DDX41 with the spliceosome. Wild-type DDX41 physically interacts with components of the U2 and U5 small nuclear ribonucleic protein complexes, and mutation of DDX41 results in disruption of these interactions and splicing defects, including aberrant exon skipping or exon retention. Abbreviations: ex, exon; DDX41 mut, DDX41 mutated; mRNA, messenger RNA. Cancer Cell 2015 27, 609-611DOI: (10.1016/j.ccell.2015.04.013) Copyright © 2015 Elsevier Inc. Terms and Conditions